News
A. The Food and Drug Administration has approved montelukast to treat asthma, exercise-induced bronchoconstriction (trouble ...
9h
Rough Draft Atlanta on MSNCVS Health withholds coverage for new HIV prevention drug
CVS Health, one of the nation’s largest pharmacy benefit manager companies that play a lead role in deciding which drugs are ...
A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...
Texas and Florida, which have near-total abortion bans, said nationwide access to mifepristone makes it impossible for the ...
The agency issued warnings to companies that make foam and whipped sunscreens, but that doesn’t necessarily mean the products ...
The Food and Drug Administration has authorized emergency use of animal drugs to treat and prevent infestations of the New ...
Lead is toxic to people of any age or health status and higher exposure levels can lead to neurological changes ...
The U.S. Food and Drug Administration has denied approval for PTC Therapeutics' oral medication for a rare genetic disorder ...
The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...
Dawnzera is the third medicine cleared by U.S. regulators this year for the rare genetic condition, and the second wholly owned medicine Ionis has brought to market.
LMI will help the Food and Drug Administration update agency business operations and processes through the company’s position on a five-year, $149 million blanket purchase agreement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results